17965 results
-
List item
Human medicine European public assessment report (EPAR): Nexium Control (updated)
esomeprazole, Gastroesophageal Reflux
Date of authorisation: 26/08/2013, Revision: 15, Authorised, Last updated: 03/03/2021 -
List item
Human medicine European public assessment report (EPAR): Tandemact (updated)
pioglitazone, glimepiride, Diabetes Mellitus, Type 2
Date of authorisation: 08/01/2007, Revision: 18, Authorised, Last updated: 02/03/2021 -
List item
Human medicine European public assessment report (EPAR): Glustin (updated)
pioglitazone hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 11/10/2000, Revision: 26, Authorised, Last updated: 02/03/2021 -
List item
Human medicine European public assessment report (EPAR): Vyndaqel (updated)
tafamidis, Amyloidosis
Date of authorisation: 16/11/2011,
, 
, 
, Revision: 18, Authorised, Last updated: 02/03/2021
-
List item
Human medicine European public assessment report (EPAR): Neupro (updated)
rotigotine, Restless Legs Syndrome, Parkinson Disease
Date of authorisation: 15/02/2006, Revision: 30, Authorised, Last updated: 02/03/2021 -
List item
Human medicine European public assessment report (EPAR): Avamys (updated)
fluticasone furoate, Rhinitis, Allergic, Seasonal, Rhinitis, Allergic, Perennial
Date of authorisation: 11/01/2008, Revision: 21, Authorised, Last updated: 02/03/2021 -
List item
Human medicine European public assessment report (EPAR): COVID-19 Vaccine Moderna (updated)
CX-024414 (single-stranded, 5’-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2), COVID-19 virus infection
Date of authorisation: 06/01/2021,, 
, Authorised, Last updated: 02/03/2021
-
List item
Veterinary medicine European public assessment report (EPAR): Equisolon (updated)
Prednisolone, Horses
Date of authorisation: 12/03/2014, Revision: 7, Authorised, Last updated: 02/03/2021 -
List item
Human medicine European public assessment report (EPAR): DaTSCAN (updated)
ioflupane (123l), Tomography, Emission-Computed, Single-Photon, Lewy Body Disease, Parkinson Disease, Alzheimer Disease
Date of authorisation: 27/07/2000, Revision: 22, Authorised, Last updated: 02/03/2021 -
List item
Human medicine European public assessment report (EPAR): Privigen (updated)
human normal immunoglobulin (IVIg), Purpura, Thrombocytopenic, Idiopathic, Bone Marrow Transplantation, Immunologic Deficiency Syndromes, Guillain-Barre Syndrome, Mucocutaneous Lymph Node Syndrome
Date of authorisation: 24/04/2008, Revision: 26, Authorised, Last updated: 02/03/2021 -
List item
Human medicine European public assessment report (EPAR): Zinforo (updated)
Ceftaroline fosamil, Community-Acquired Infections, Skin Diseases, Infectious, Pneumonia
Date of authorisation: 22/08/2012, Revision: 24, Authorised, Last updated: 02/03/2021 -
List item
Human medicine European public assessment report (EPAR): Leganto (updated)
rotigotine, Restless Legs Syndrome, Parkinson Disease
Date of authorisation: 16/06/2011, Revision: 19, Authorised, Last updated: 01/03/2021 -
List item
Human medicine European public assessment report (EPAR): Lantus (updated)
insulin glargine, Diabetes Mellitus
Date of authorisation: 09/06/2000, Revision: 36, Authorised, Last updated: 01/03/2021 -
List item
Veterinary medicine European public assessment report (EPAR): Coliprotec F4/F18 (updated)
Live non-pathogenic Escherichia coli O141:K94 (F18ac) and O8:K87 (F4ac), Pigs
Date of authorisation: 09/01/2017, Revision: 3, Authorised, Last updated: 01/03/2021 -
List item
Human medicine European public assessment report (EPAR): Bortezomib Sun (updated)
bortezomib, Multiple Myeloma
Date of authorisation: 22/07/2016,
, Revision: 10, Authorised, Last updated: 01/03/2021
-
List item
Human medicine European public assessment report (EPAR): Daptomycin Hospira (updated)
daptomycin, Soft Tissue Infections, Skin Diseases, Bacterial
Date of authorisation: 22/03/2017,, Revision: 10, Authorised, Last updated: 01/03/2021
-
List item
Human medicine European public assessment report (EPAR): Nucala (updated)
Mepolizumab, Asthma
Date of authorisation: 01/12/2015, Revision: 14, Authorised, Last updated: 01/03/2021 -
List item
Human medicine European public assessment report (EPAR): Velcade (updated)
bortezomib, Multiple Myeloma
Date of authorisation: 26/04/2004, Revision: 44, Authorised, Last updated: 01/03/2021 -
List item
Human medicine European public assessment report (EPAR): Flixabi (updated)
infliximab, Spondylitis, Ankylosing, Arthritis, Rheumatoid, Crohn Disease, Colitis, Ulcerative, Arthritis, Psoriatic, Psoriasis
Date of authorisation: 26/05/2016,, 
, Revision: 16, Authorised, Last updated: 01/03/2021
-
List item
Human medicine European public assessment report (EPAR): Qutenza (updated)
capsaicin, Neuralgia
Date of authorisation: 15/05/2009, Revision: 15, Authorised, Last updated: 01/03/2021 -
List item
Veterinary medicine European public assessment report (EPAR): Draxxin (updated)
tulathromycin, Pigs, Cattle, Sheep
Date of authorisation: 11/11/2003, Revision: 24, Authorised, Last updated: 01/03/2021 -
List item
Human medicine European public assessment report (EPAR): Karvezide (updated)
irbesartan, hydrochlorothiazide, Hypertension
Date of authorisation: 16/10/1998, Revision: 40, Authorised, Last updated: 01/03/2021 -
List item
Human medicine European public assessment report (EPAR): Topotecan Hospira (updated)
topotecan, Uterine Cervical Neoplasms, Small Cell Lung Carcinoma
Date of authorisation: 09/06/2010, Revision: 16, Authorised, Last updated: 01/03/2021 -
List item
Human medicine European public assessment report (EPAR): Herzuma (updated)
trastuzumab, Stomach Neoplasms, Breast Neoplasms
Date of authorisation: 08/02/2018,, , Revision: 11, Authorised, Last updated: 01/03/2021
-
List item
Human medicine European public assessment report (EPAR): Stelara (updated)
Ustekinumab, Psoriasis, Arthritis, Psoriatic, Crohn Disease
Date of authorisation: 15/01/2009, Revision: 34, Authorised, Last updated: 01/03/2021